Caplin Point Laboratories (CAPLIPOINT) Share Price Fall Streak: Second Straight Session Decline
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Caplin Point Laboratories Share Price was lower in its second straight session, and the cumulative move across the streak stands at -6.55% from the 2026-10-08 base of Rs 2,650.95. The latest traded price was Rs 2,477.20 as of 09 October 2026 at 9:53:20 AM IST, while the latest data confirms the pattern but does not establish a company-specific cause for the continued decline.
Caplin Point Laboratories has a market capitalisation of Rs 20,150.32 Cr, which places the move in the context of a large cap healthcare stock rather than a small, thinly valued name. For a reader tracking Caplin Point Laboratories Share Price Fall Streak, the more important signal is that two lower sessions in a row carry different information from a single-day dip: they show a running weakness across sessions, while still leaving the fundamental base for Caplin Point Laboratories Share Price unchanged during the period.
Caplin Point Laboratories (CAPLIPOINT) Share Price Fall Streak: Consecutive Decline Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,477.2 |
| Previous Close | Rs 2,550.65 |
| Today's Move | -Rs 73.45 (-2.88%) |
| Open | Rs 2,538.4 |
| High | Rs 2,577.65 |
| Low | Rs 2,475.75 |
| Market Capitalisation | Rs 20,150.32 crore |
Caplin Point Laboratories Share Price opened at Rs 2,538.40, moved to a high of Rs 2,577.65 and touched a low of Rs 2,475.75 during the session. The latest traded price stood at Rs 2,477.20, below the previous close of Rs 2,550.65 by Rs 73.45, or 2.88%. That places Caplin Point Laboratories Share Price near the lower end of the day’s range, close to the session low rather than the session high.
The decline is notable because it comes after the earlier fall that started the streak, so the current reading is not just a one-off move. Caplin Point Laboratories Share Price Fall Streak now reflects two consecutive lower sessions, and the cumulative change of -6.55% from Rs 2,650.95 gives a clearer picture of the current tone. The company remains a large cap stock with a market capitalisation of Rs 20,150.32 Cr, and that size matters when reading the day’s move alongside the wider valuation backdrop. The price action therefore leads naturally into fundamentals.
What the Consecutive Declines Show
Caplin Point Laboratories Share Price Fall Streak is more informative than a single-day slide because it measures how the stock has behaved across two sessions, not just one. The cumulative fall of 6.55% from the streak base of Rs 2,650.95 shows that the latest price is being set against a lower reference point than the earlier session.
For Caplin Point Laboratories Share Price, the second straight session matters because it changes the way investors read the move: they are no longer looking only at one weak print, but at a repeated pattern of lower trading. Univest figures confirm the price action, but they do not point to a specific company trigger. That makes the streak a price-pattern story first, with the numbers themselves doing the explanatory work.
Caplin Point Laboratories (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,150.32 crore |
| P/E Ratio | 29.14x |
| P/B Ratio | 5.28x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.31% |
Caplin Point Laboratories (CAPLIPOINT) fundamental metrics show P/E 29.14x, P/B 5.28x, ROE 20.79%, ROCE 24.97%. Taken on their own, these numbers offer context rather than a trading signal.
Caplin Point Laboratories has a market capitalisation of Rs 20,150.32 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 29.14x, P/B at 5.28x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.28x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.14x |
| Benchmark Median P/E | 31.28x |
| Benchmark Average P/E | 47.09x |
| Benchmark P/E Range | 3.56x to 678.22x |
| Company P/B Ratio | 5.28x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.25x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 20,150.32 crore |
| Benchmark Median Market Cap | Rs 821.44 crore |
| Benchmark Average Market Cap | Rs 14,054.13 crore |
Caplin Point Laboratories (CAPLIPOINT) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Caplin Point Laboratories (CAPLIPOINT) has a P/E ratio of 29.14x, which is below the benchmark median of 31.28x, a difference of -6.84%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.61%, a difference of +79.07%. Caplin Point Laboratories (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.46%, a difference of +85.51%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,27,861.41 | 34.76 | 4.86 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,54,318.9 | 85.21 | 14.11 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,79,153.26 | 81.53 | 19.81 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,111.94 | 24.65 | 4.13 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,034.16 | 98.83 | 19.16 | 18.31 | 18.2 |
Caplin Point Laboratories (CAPLIPOINT) has a P/E ratio of 29.14x compared with the displayed peer median of 81.53x. The comparison is relative and should not be read as a recommendation. Its ROE of 20.79% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories (CAPLIPOINT) has a market capitalisation of Rs 20,150.32 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price is in a second straight session of decline, with the cumulative move at -6.55%.
- The latest traded price of Rs 2,477.20 is below the previous close of Rs 2,550.65 by Rs 73.45.
- Caplin Point Laboratories Share Price remains backed by ROE of 20.79% and ROCE of 24.97%.
- The stock’s P/E of 29.14 is below the same-industry benchmark median of 31.28.
- Caplin Point Laboratories Share Price still sits within a large cap market-cap context at Rs 20,150.32 Cr.
About Caplin Point Laboratories
Caplin Point Laboratories operates in Healthcare and the Pharmaceuticals & Drugs industry. The business context relevant to Caplin Point Laboratories Share Price is its place within a large-cap pharma set where return ratios and valuation multiples often matter as much as the daily move.
For a reader following Caplin Point Laboratories Share Price Fall Streak, the company profile matters mainly because it helps interpret the market’s current reading of the stock. The available financial snapshot points to earnings strength through EPS, book value support and return ratios, while the share price remains the variable moving across the streak.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories (CAPLIPOINT) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Caplin Point Laboratories Share Price on Univest for live price updates, valuation ratios, 52-week levels and market context. Caplin Point Laboratories Share Price, Caplin Point Laboratories Stock Analysis and Caplin Point Laboratories Fundamental Analysis are all easier to follow when the key numbers sit in one place.
For readers monitoring Caplin Point Laboratories Share Price Today, the Univest view also helps connect the current move with the company’s market capitalisation, return ratios and peer comparison in a single place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Caplin Point Laboratories Share Price falling today?
Ans. Caplin Point Laboratories Share Price is lower in its second straight session, and the latest traded price is Rs 2,477.20 versus the previous close of Rs 2,550.65. According to Univest data, the pattern is confirmed, but no company-specific catalyst.
What is the current Caplin Point Laboratories Share Price?
Ans. Caplin Point Laboratories Share Price was last traded at Rs 2,477.20 as of 09 October 2026 at 9:53:20 AM IST. That is Rs 73.45 below the previous close and reflects a 2.88% decline in trade.
How much has Caplin Point Laboratories Share Price fallen across the streak?
Ans. The streak began from Rs 2,650.95 on 2026-10-08 and now shows a cumulative decline of 6.55%. Caplin Point Laboratories Share Price has therefore moved lower across two consecutive sessions, not just one session.
What was the day’s range for Caplin Point Laboratories Share Price?
Ans. Caplin Point Laboratories Share Price opened at Rs 2,538.40, touched a high of Rs 2,577.65 and a low of Rs 2,475.75. The latest traded price sat near the lower end of that range during the session.
What is the market capitalisation of Caplin Point Laboratories ?
Ans. Caplin Point Laboratories has a market capitalisation of Rs 20,150.32 Cr. That places Caplin Point Laboratories Share Price in a large cap context within the Healthcare sector and the Pharmaceuticals & Drugs industry.
What does Caplin Point Laboratories Share Price look like on valuation?
Ans. Caplin Point Laboratories Share Price trades at a P/E ratio of 29.14 and a P/B ratio of 5.28. The lower share price in the streak changes the multiples only through price, while EPS and book value remain Rs 87.53.
How does Caplin Point Laboratories compare with its industry benchmark?
Ans. Caplin Point Laboratories Share Price has a P/E below the same-industry median of 31.28 and ROE and ROCE above the benchmark medians of 11.61% and 13.46%. The P/B ratio remains above the benchmark median of 2.85.
How does Caplin Point Laboratories compare with peers?
Ans. Caplin Point Laboratories Share Price shows a smaller market capitalisation than Sun Pharmaceutical Industries, Divi’s Laboratories and Torrent Pharmaceuticals On returns, its ROE of 20.79% and ROCE of 24.97% compare well with several listed peers.
What should investors monitor next in Caplin Point Laboratories Share Price?
Ans. Investors tracking Caplin Point Laboratories Share Price should monitor whether the two-session decline extends or stabilises, alongside future fundamentals such as earnings, book value and valuation ratios. The current streak is a price pattern, not a confirmed operating change.
